Viral hepatitis induces hepatocellular cancer: What can we learn from epidemiology comparing iran and worldwide findings?

Hepatitis Monthly

Volumn 12, Issue 10 HCC, 2012, Pages 7879-

  Smolle, Elisabeth ^a   Zöhrer, Evelyn ^a   Bettermann, Kira ^a   Haybaeck, Johannes ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Carcinoma; Hepatocellular; Iran; Viral hepatitis

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; HEPATITIS VACCINE;

DELTA AGENT HEPATITIS; GENE MUTATION; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYGIENE; INFECTION RATE; IRAN; LIVER CELL CARCINOMA; NONHUMAN; PREVALENCE; REVIEW; RISK FACTOR; SCREENING; VACCINATION; VIRUS TRANSMISSION;

EID: 84871487814     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: 10.5812/hepatmon.7879     Document Type: Review

References (67)

1. DiBisceglie AM, Hoofnagle JH. Chronic viral hepatitis. In: Zankim D, Boyer TD,. Hepatology: A Textbook of Liver Disease: W.B. Saunders Co; 2007. p. 1299-329.
2. MacSween RNM. Pathology of the Liver. Churchill Livingstone. 2003;
3. Koziel M. Immunology of viral hepatitis. American J Med. 1996;100:98-109.[DOI]
4. Wanless IR, Wong F, Blendis LM, Greig P, Heathcote EJ, Levy G. Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension. Hepatology. 1995;21(5):1238-47.[DOI]
5. Blum HE. Hepatitis viruses: genetic variants and clinical significance. Int J Clin Lab Res. 1997;27(4):213-24.[DOI] [PubMed]
6. Cesaro S, Petris MG, Rossetti F, Cusinato R, Pipan C, Guido M, et al. Chronic hepatitis C virus infection after treatment for pediatric malignancy. Blood. 1997;90(3):1315-20.[PubMed]
7. Guido M, Thung SN, Fattovich G, Cusinato R, Leandro G, Cecchetto A, et al. Intrahepatic expression of hepatitis B virus antigens: effect of hepatitis C virus infection. Mod Pathol. 1999;12(6):599-603.[PubMed]
8. Soriano V, Rodriguez-Rosado R, Garcia-Samaniego J. Management of chronic hepatitis C in HIV-infected patients. AIDS. 1999;13(5):539-46.[DOI] [PubMed]
9. Kane M, Gendon Y, Lambert P. Hepatitis B in 1990 - where are we and where are we going? In: Hollinger FB, Lemon SM, Margolis HS,. Viral Hepatitis and Liver Disease. Baltimore: Williams and Wilkins; 1991. p. 706-10.
10. Bahramali G, Sadeghizadeh M, Amini-Bavil-Olyaee S, Alavian SM, Behzad-Behbahani A, Adeli A, et al. Clinical, virologic and phylogenetic features of hepatitis B infection in Iranian patients. World J Gastroenterol. 2008;14(35):5448-53.[DOI] [PubMed]
11. Poorolajal J, Majdzadeh R. Prevalence of chronic hepatitis B infection in Iran: a review article. J Res Med Sci. 2009;14(4):249-58. [PubMed]
12. Sali S, Bshtar R, Alavian SM. Risk factors in chronic hepatitis B infection: A case-control study. Hepat Mon. 2005;5:109-15.
13. Wright TL, Terrault NA, Ganem D. Hepatitis B virus In: Richman DD, Whitley RJ, Hayden FG,. Clin Virol. New York: Churchill Livingstone; 1996. p. 663-82.
14. Poustchi H. Hepatitis B virus infection in iran. Iranian J Clin Infect Dis. 2007;2(1):37-51.
15. Farzadegan H. The prevalence of HBsAg, HBsAb, and HbeAb in healthy blood donors and high risk groups in iran. Sang. 1979;73:182. [DOI]
16. Yu H, Yuan Q, Ge SX, Wang HY, Zhang YL, Chen QR, et al. Molecular and phylogenetic analyses suggest an additional hepatitis B virus genotype "I". PLoS One. 2010;5(2):e9297[DOI] [PubMed]
17. Mohebbi SR, Amini-Bavil-Olyaee S, Zali N, Noorinayer B, Derakhshan F, Chiani M, et al. Molecular epidemiology of hepatitis B virus in Iran. Clin Microbiol Infect. 2008;14(9):858-66. [DOI] [PubMed]
18. Kay A, Zoulim F. Hepatitis B virus genetic variability and evolution. Virus Res. 2007;127(2):164-76. [DOI] [PubMed]
19. Ozaslan M, Ozaslan E, Barsgan A, Koruk M. Mutations in the S gene region of hepatitis B virus genotype D in Turkish patients. J Genet. 2007;86(3):195-201. [DOI] [PubMed]
20. Poustchi H, Mohamadkhani A, Bowden S, Montazeri G, Ayres A, Revill P, et al. Clinical significance of precore and core promoter mutations in genotype D hepatitis B-related chronic liver disease. J Viral Hepat. 2008;15(10):753-60. [DOI] [PubMed]
21. Zali MR, Mohammad K, Noorbala AA, Noorimayer B, Shahraz S. Rate of hepatitis B seropositivity following mass vaccination in the Islamic Republic of Iran. East Mediterr Health J. 2005;11(1-2):62-7.[PubMed]
22. McMahon BJ. Natural history of chronic hepatitis B - clinical implications. Medscape J Med. 2008;10(4):91. [PubMed]
23. Abdolahi N, Keshtkar A, Semnani S, Roshandel G, Sehrat S, Joshaghani H. HBV seroprevalence among golestan adults. Iranian J Epidem. 2006;4(1):35-40.
24. McMurray RW. Hepatitis C-associated autoimmune disorders. Rheum Dis Clin North Am. 1998;24(2):353-74. [DOI]
25. Ganem D. Hepadnaviridae and their replication. In: Fields BN, Knipe DM,. Fields' virology 2. New York, NY: Raven Press; 1990.
26. Hoofnagle JH, Dusheiko GM, Seeff LB, Jones EA, Waggoner JG, Bales ZB. Seroconversion from hepatitis B e antigen to antibody in chronic type B hepatitis. Annals of internal medicine. 1981;94(6):744-8. [PubMed]
27. Hollinger F. Hepatitis B virus. In: Fields BN, Knipe DM,. Fields' virology 2. New York, NY: Raven Press; 199 pp.
28. Seeff LB. Transfusion-associated hepatitis B: past and present. Transfusion med rev [Historical Article Review].1988;2(4):204-14. [DOI]
29. Davison F, Alexande rGJ, Trowbridge R, Fagan EA, Williams R. Detection of hepatitis B virus DNA in spermatozoa, urine, saliva and leucocytes, of chronic HBsAg carriers. A lack of relationship with serum markers of replication. J Hepatology. 1987;4(1):37-44. [DOI]
30. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Recomm Rep. 1991;40(RR-13):1-25.
31. Beasley RP, Hwan gLY. Postnatal infectivity of hepatitis B surface antigen-carrier mothers. J Infect Dis. 1983;147(2):185-90. [DOI]
32. Botha JF, Ritchie MJ, Dusheiko GM, Mouton HW, Kew MC. Hepatitis B virus carrier state in black children in Ovamboland: role of perinatal and horizontal infection. Lancet. 1984;1(8388):1210-2. [DOI]
33. Krugman S, Giles JP, Hammond J. Infectious hepatitis. Evidence for two distinctive clinical, epidemiological, and immunological types of infection. JAMA. 1967;200(5):365-73[DOI] [PubMed]
34. WHO. Hepatitis C: Global prevalence.: WHO Weekly Epidemiological Record. 1997 Available from: http://www.who.int/csr/disease/ hepatitis/Hepc.pdf.
35. Alter MJ. Epidemiology of hepatitis C Hepatology. 1997;26(3 Suppl 1):62S-5S.[DOI] [PubMed]
36. Ohto H, Terazawa S, Sasaki N, Hino K, Ishiwata C, Kako M, et al. Transmission of hepatitis C virus from mothers to infants. The Vertical Transmission of Hepatitis C Virus Collaborative Study Group. N Engl J Med. 1994;330(11):744-50. [DOI] [PubMed]
37. Chu CM, Sheen IS, Liaw YF. The role of hepatitis C virus in fulminant viral hepatitis in an area with endemic hepatitis A and B. Gastroenterology. 1994;107(1):189-95. [PubMed]
38. Pagliaro L, Peri V, Linea C, Camma C, Giunta M, Magrin S. Natural history of chronic hepatitis C. Ital J Gastroenterol Hepatol. 1999;31(1):28-44. [PubMed]
39. Theise ND. Cirrhosis and hepatocellular neoplasia: more like cousins than like parent and child. Gastroenterology. 1996;111(2):526-8. [DOI] [PubMed]
40. Missale G, Bertoni R, Lamonaca V, Valli A, Massari M, Mori C, et al. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response. J Clin Invest. 1996;98(3):706-14. [DOI] [PubMed]
41. Schluger LK, Sheiner PA, Thung SN, Lau JY, Min A, Wolf DC, et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology. 1996;23(5):971-6. [DOI] [PubMed]
42. Ramia S, Eid-Fares J. Distribution of hepatitis C virus genotypes in the Middle East. Int J Infect Dis. 2006;10(4):272-7. [DOI] [PubMed]
43. Keyvani H, Alizadeh AH, Alavian SM, Ranjbar M, Hatami S. Distribution frequency of hepatitis C virus genotypes in 2231 patients in Iran. Hepatol Res. 2007;37(2):101-3. [DOI] [PubMed]
44. Zahedi MJ, Darvish-Moghadon S. Frequency of hepatitis B and C infection among hemophiliac patients in kerman. J Kerman Univ Med Sci. 2004;3(11):131-5.
45. Sharifi-Mood B, Eshghi P, Sanei-Moghaddam E, Hashemi M. Hepatitis B and C virus infections in patients with hemophilia in Zahedan, southeast Iran. Saudi Med J. 2007;28(10):1516-9. [PubMed]
46. Alavian SM. We have more data regarding epidemiology of hepatitis D in iran but there are defects to be filled yet! Hepat Mon. 2008;8:245-7.
47. Tohme RA, Holmberg SD. Is sexual contact a major mode of hepatitis C virus transmission? Hepatology. 2010;52(4):1497-505. [DOI] [PubMed]
48. Casey JL. Hepatitis delta virus. Genetics and pathogenesis. Clin Lab Med. 1996;16(2):451-64. [PubMed]
49. Vaziri S, Mansouri F, Sayad B, Afsharian M, Janbaksh A, Karami M. Hepatitis D virus infection among HIV-HBV co-infected patients in kermanshah, west of iran. Hepat Mon. 2008;8:252-7.
50. Moghani Lankarani M, Doroudi T, Haji-Beigi B, et al. Frequency and risk factors of hepatitis D virus in hepatitis B patients. Govaresh. 2005;10:21-6.
51. Shahinsaz L, Sabahi F, Karimi M, Behzadian F, Alavian SM, Zand V. Detection and genotyping of hepatitis D virus from HBsAg positive patients in iran using RT-PCR. Iranian J Biotech. 2006;4:174-9.
52. Gholamreza R, Shahryar S, Abbasali K, Hamidreza J, Abdolvahab M, Khodaberdi K, et al. Seroprevalence of hepatitis B virus and its co-infection with hepatitis D virus and hepatitis C virus in Iranian adult population. Indian J Med Sci. 2007;61(5):263-8. [DOI] [PubMed]
53. Palmer CN, Hsu MH, Griffin KJ, Raucy JL, Johnson EF. Peroxisome proliferator activated receptor-alpha expression in human liver. Mol Pharmacol. 1998;53(1):14-22. [PubMed]
54. Grisham JW. Interspecies comparison of liver carcinogenesis: Implications for cancer risk assessment. Carcinogenesis. 1996;18:59-81. [DOI]
55. Yan RQ, Su JJ, Huang DR, Gan YC, Yang C, Huang GH. Human hepatitis B virus and hepatocellular carcinoma. I. Experimental infection of tree shrews with hepatitis B virus. J Cancer Res Clin Oncol. 1996;122(5):283-8. [DOI] [PubMed]
56. Snibson KJ, Bhathal PS, Hardy CL, Brandon MR, Adams TE. High, persistent hepatocellular proliferation and apoptosis precede hepatocarcinogenesis in growth hormone transgenic mice. Liver. 1999;19(3):242-52. [DOI] [PubMed]
57. Roberts RA, Soames AR, Gill JH, James NH, Wheeldon EB. Non-genotoxic hepatocarcinogens stimulate DNA synthesis and their withdrawal induces apoptosis, but in different hepatocyte populations. Carcinogenesis. 1995;16(8):1693-8. [DOI] [PubMed]
58. Tannapfel A, Geissler F, Köckerling F, Katalinic A, Hauss J, Wittekind C. Apoptosis and proliferation in relation to histopathological variables and prognosis in hepatocellular carcinoma. J Pathology. 1999;187:439-45.
59. Bettermann K, Vucur M, Haybaeck J, Koppe C, Janssen J, Heymann F, et al. TAK1 suppresses a NEMO-dependent but NF-kappaB-independent pathway to liver cancer. Cancer Cell. 2010;17(5):481-96. [DOI] [PubMed]
60. Nakamoto Y, Guidotti LG, Kuhlen CV, Fowler P, Chisari FV. Immune pathogenesis of hepatocellular carcinoma. J Exp Med. 1998;188(2):341-50. [DOI] [PubMed]
61. Koike K, Moriya K, Iino S, Yotsuyanagi H, Endo Y, Miyamura T, et al. High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology. 1994;19(4):810-9. [DOI] [PubMed]
62. Huang SN, Chisari FV. Strong, sustained hepatocellular proliferation precedes hepatocarcinogenesis in hepatitis B surface antigen transgenic mice. Hepatology. 1995;21(3):620-6. [DOI]
63. Wirth S, Guidotti LG, Ando K, Schlicht HJ, Chisari FV. Breaking tolerance leads to autoantibody production but not autoimmune liver disease in hepatitis B virus envelope transgenic mice. J Immunol. 1995;154(5):2504-15. [PubMed]
64. Vainer GW, Pikarsky E, Ben-Neriah Y. Contradictory functions of NF-kappaB in liver physiology and cancer. Cancer Lett. 2008;267(2):182-8. [DOI] [PubMed]
65. Ware CF. Network communications: lymphotoxins, LIGHT, and TNF. Annu Rev Immunol. 2005;23:787-819. [DOI] [PubMed]
66. Zhu N, Khoshnan A, Schneider R, Matsumoto M, Dennert G, Ware C, et al. Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol. 1998;72(5):3691-7. [PubMed]
67. Haybaeck J, Zeller N, Wolf MJ, Weber A, Wagner U, Kurrer MO, et al. A lymphotoxin-driven pathway to hepatocellular carcinoma. Cancer Cell. 2009;16(4):295-308. [DOI] [PubMed]